Literature DB >> 6057793

Degradation of streptococcal cell wall antigens in vivo.

J H Schwab, S H Ohanian.   

Abstract

Specific chemical modification of group A polysaccharide antigen to the A-variant structure was demonstrated in the lymphoid organs of mice by autoradiography by use of radioantibodies specific for these structures. Both antigenic moieties persisted and were still discerned 10 weeks after injection of the group A cell wall. In rabbit skin, the group A specificity was altered after a prolonged period. Unlike the situation for the mouse, polysaccharide A was not converted to A-variant structure, but another specificity common to both polysaccharides persisted at the site of injection. Mucopeptide, separated from the polysaccharide of group A cell walls, was eliminated from the site of injection in rabbit skin between 4 and 8 hr after injection. Group D streptococcal cell walls were also rapidly eliminated from tissue, and were no longer detectable 8 hr after injection into rabbit skin or 24 hr after injection into mice. The rapid degradation of these structures was correlated with their susceptibility to lysozyme in vitro and was in contrast to the prolonged persistence of group A cell walls, which were completely resistant to egg white lysozyme. This persistence in tissue correlated with the capacity of group A cell wall fragments to induce a chronic inflammatory process, whereas the isolated mucopeptide or group D cell walls produced only an acute necrotoxic reaction.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6057793      PMCID: PMC276831          DOI: 10.1128/jb.94.5.1346-1352.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

1.  Biological properties of streptococcal cell-wall particles. 3. Dermonecrotic reaction to cell-wall mucopeptides.

Authors:  E M Abdulla; J H Schwab
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

2.  Rheumatic-like cardiac lesions in mice.

Authors:  W J Cromartie; J G Craddock
Journal:  Science       Date:  1966-10-14       Impact factor: 47.728

3.  Biological properties of streptococcal cell-wall particles. I. Determinants of the chronic nodular lesion of connective tissue.

Authors:  J H Schwab
Journal:  J Bacteriol       Date:  1965-11       Impact factor: 3.490

4.  Group A streptococcus polysaccharide: studies on its preparation, chemical composition, and cellular localization after intravenous injection into mice.

Authors:  W C SCHMIDT
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

5.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

6.  Persistence of group a streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue.

Authors:  S H Ohanian; J H Schwab
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

7.  Further studies on the chemical basis for serological specificity of Group A streptococcal carbohydrate.

Authors:  M McCARTY
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

8.  DETECTION OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODIES IN HUMAN SERA.

Authors:  W W KARAKAWA; C K OSTERLAND; R KRAUSE
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

  8 in total
  38 in total

1.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

2.  Bacteriolysis is inhibited by hydrogen peroxide and by proteases.

Authors:  I Ginsburg
Journal:  Agents Actions       Date:  1989-11

3.  Effects of streptococcal cell wall fragments on phagocytosis and tissue culture cells.

Authors:  J M Jones; J H Schwab
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

4.  Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates.

Authors:  R Striker; M E Kline; R A Haak; R F Rest; R S Rosenthal
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.

Authors:  A Fox; R R Brown; S K Anderle; C Chetty; W J Cromartie; H Gooder; J H Schwab
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

Authors:  S A Stimpson; R A Lerch; D R Cleland; D P Yarnall; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

7.  Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.

Authors:  P A Leong; J H Schwab; M S Cohen
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line.

Authors:  M W Vermeulen; G R Gray
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Reduction of wall degradability of clindamycin-treated staphylococci within macrophages.

Authors:  J Wecke; L Johannsen; P Giesbrecht
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  The effect of leukocyte hydrolases on bacteria VIII. The combined effect of leukocyte extracts, lysozyme, enzyme "cocktails," and penicillin on the lysis ofStaphylococcus aureus and group a streptococci in vitro.

Authors:  C Efrati; T Sacks; N Ne'eman; M Lahav; I Ginsburg
Journal:  Inflammation       Date:  1976-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.